Evidence map›Paper›PMID 32393498›Full record

ArticleAntimicrobial agents and chemotherapy2020

Plasmodium falciparum Isolates Carrying

Inke N D Lubis, Hendri Wijaya, Munar Lubis, Chairuddin P Lubis, Khalid B Beshir, Colin J Sutherland

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Reversal of Chloroquine Resistance inInternational journal of molecular sciences · 2026
    Article
  3. Article
  4. Review
  5. Recurrence ofOpen forum infectious diseases · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Inke N D LubisDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Hendri WijayaDepartment of Paediatrics, University of Sumatera Utara, Medan, Indonesia.
Munar LubisDepartment of Paediatrics, University of Sumatera Utara, Medan, Indonesia.
Chairuddin P LubisDepartment of Paediatrics, University of Sumatera Utara, Medan, Indonesia.
Khalid B BeshirDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Colin J SutherlandDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom colin.sutherland@lshtm.ac.uk.ORCID 0000-0003-1592-6407
Universitas Sumatera Utara · IDLondon School of Hygiene & Tropical Medicine · GB

Funding

Medical Research Council MR/T016124/1
6 · The paper itself

Abstract

Artemisinin-based combination therapy (ACT) is the first-line antimalarial regimen in Indonesia. Susceptibility of

Indexed as

AntimalarialsMalaria, FalciparumAllelesArtemetherArtemether, Lumefantrine Drug CombinationATP-Binding Cassette, Sub-Family C ProteinsCross-Sectional StudiesDrug ResistanceHumansIndonesiaPlasmodium falciparumProtozoan ProteinsAntimalarialsArtemetherArtemether, Lumefantrine Drug CombinationATP-Binding Cassette, Sub-Family C ProteinsProtozoan Proteinsantimalarial agentsdrug resistance mechanismsIndonesia

Identifiers

PMID32393498
PMCPMC7526839
OpenAlexW3024171484

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.